News Center.
In the news:
AAPL.
CAT.
SVU.
BTU.
ACOM.
..
.
Stereotaxis Elects Euan S. Thomson, Ph.D., to Board of Directors
October 22, 2012 4:18 PM ET.
Share
0
TICKERS IN THIS ARTICLE.
NAME
LAST
CHNG
% CHNG
STXS
1.90
+0.67
+54.47
ST. LOUIS, Oct. 22, 2012 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS +54.47%, news) today announced that Euan Thomson has been elected to its Board of Directors. The former President and CEO of Accuray Incorporated, Dr. Thomson, a medical physicist, has nearly 30 years experience in scientific research and strategic business leadership. He assumes the Board seat vacated by Christopher Alafi upon his retirement this year.
"Euan's unique blend of business acumen and medical innovation will be a tremendous asset as we continue to work toward market leadership and profitable growth through leading-edge, robotic solutions to important clinical challenges," said William Mills, Stereotaxis Board Chairman. "He has had outstanding success leading transformational change at Accuray and brings rich insight into securing global clinical adoption of groundbreaking technology."
Dr. Thomson holds a Master's in Radiation Physics and a Doctorate in Medical Physics from the University of London. Following his medical physics training, he devoted more than 15 years to research, teaching, clinical practice and administration with the United Kingdom Health Care System. During that time he worked as a consultant, advising companies and hospitals on scientific development, product marketing and management on an international scale. In 1999, Dr. Thomson moved to the U.S. to assume the reins at Photoelectron Corporation, a Boston-based company specializing in miniature x-ray technology for the medical and industrial markets.
Dr. Thomson was appointed President and CEO of Accuray, a medical capital equipment company, in 2002. During his 10-year tenure, he grew Accuray from a start-up to a public company with more than 1,000 employees, generating more than $400M in annual revenue. Dr. Thomson oversaw expansion of distribution channels to include more than 80 countries and development of the patent portfolio to approximately 300 US and foreign patents. Accuray built clinical programs that resulted in treatments to hundreds of thousands of patients worldwide and built an installed base exceeding 600 systems. In 2009, Dr. Thomson was recognized as Ernst and Young "Entrepreneur of the Year" in healthcare for Northern California. He currently serves as the Chair of the American Cancer Society's "CEO's Against Cancer" (California division) and is a Board member of the Hospice of the Valley. Dr. Thomson recently announced his resignation from Accuray, where it is anticipated he will continue to serve as a consultant.
"I'm excited to join an accomplished Board of Directors in providing strategic guidance to a company focused on transforming the world of interventional medicine," Dr. Thomson said of his appointment to the Stereotaxis Board. "Stereotaxis is poised for profitability and well positioned for growth in an expanding worldwide market. I look forward to being part of the future of an enterprising organization."
Recent STXS News
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/23/2024 09:10:48 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/23/2024 09:06:16 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 08/15/2024 09:26:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 05:40:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:07:26 PM
- Stereotaxis Reports 2024 Second Quarter Financial Results • GlobeNewswire Inc. • 08/12/2024 08:05:00 PM
- Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX • GlobeNewswire Inc. • 08/12/2024 08:03:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 01:05:11 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/22/2024 08:05:18 PM
- Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024 • GlobeNewswire Inc. • 07/22/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2024 09:06:40 PM
- Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir • GlobeNewswire Inc. • 07/18/2024 08:13:00 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/30/2024 06:35:22 PM
- Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment • GlobeNewswire Inc. • 05/29/2024 12:25:00 PM
- Stereotaxis Receives CE Mark Recertification Under EU’s MDR Regulatory Framework • GlobeNewswire Inc. • 05/24/2024 12:37:00 PM
- First Heart Rhythm Patients in Southern Italy Treated with Advanced Robotic Technology • GlobeNewswire Inc. • 05/22/2024 12:42:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 09:00:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 02:35:45 PM
- Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa • GlobeNewswire Inc. • 05/15/2024 12:52:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:10:46 PM
- Stereotaxis Reports 2024 First Quarter Financial Results • GlobeNewswire Inc. • 05/13/2024 08:03:00 PM
- Stereotaxis Announces Definitive Agreement to Acquire Access Point Technologies • GlobeNewswire Inc. • 05/13/2024 08:02:00 PM
- Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024 • GlobeNewswire Inc. • 04/22/2024 11:51:00 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/08/2024 08:21:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 09:06:02 PM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM